Analyst Ratings for Prometheus Biosciences Inc (RXDX)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 2.9 / 10
Percentile Rank: 24%
Rating Score: 2.9 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/10/2023 | Jefferies | Michael Yee | Downgrade | Hold (Buy) |
200.00 (160.00) |
194.22 (199.92) |
2.93% | Details |
| 4/18/2023 | Wells Fargo | Chris M. Carey | Downgrade | Equal Weight (Overweight) |
200.00 (N/A) |
114.01 (199.92) |
75.35% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


